Regulation And Legal
Mahamaya Lifesciences Reports No Promoter Share Encumbrance for FY26
Mahamaya Lifesciences filed a regulatory disclosure confirming no encumbrance on promoter shares for FY 2025-26.
The disclosure, made under SEBI's takeover regulations, was submitted to the BSE on Apr
